Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection [14]

Lancet

Volumn 347, Issue 9015, 1996, Pages 1630-1631

  Kreiss, C ^a   Buclin, T ^a   Cosma, M ^a   Corthesy Theulaz, I ^a   Michetti, P ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

UREASE;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERANCE; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; LETTER; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030014767     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91119-8     Document Type: Letter

References (5)

1. Ka Eaton Cl Brooks Dr Morgan S. Krakowka Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets Infect Immun 59 1991 2470 2475
2. Rl Ferrero A. Labigne Cloning, expression and sequencing of Helicobacter felis urease genes Mol Microbiol 9 1993 323 333
3. P. Michetti I. Corthesy-Theulaz C. Davin Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease Gastroenterology 107 1994 1002 1011
4. I. Corthésy-Theulaz N. Porta M. Glauser Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice Gastroenterology 109 1995 115 121
5. Ab Price The Sydney System: histological division J Gastroenterol 6 1991 209 222